Will the D.C. Council overturn Initiative 77? Can a Republican win a U.S. Senate seat in Maryland? And what's going on with the Montgomery County Executive race?
Guest Host: Jen Golbeck
The chief executive of a pharmaceutical company caused a public outcry when he acquired sole U.S. rights to distribute a lifesaving drug and raised the price by more than 5000 percent. But the issue goes well beyond one company and one former hedge fund manager. A number of companies have been quietly cornering the market on older, off-patent drugs–and hiking prices. We speak with a medical historian about the economics of drug pricing, and why “generic” doesn’t guarantee competition.
- Jeremy Greene MD; Professor of Medicine and the History of Medicine, Johns Hopkins University School of Medicine; Author, “Generic: The Unbranding of Modern Medicine.”
Most Recent Shows
Artists are often on the frontlines of gentrification, moving into lower-income neighborhoods, making those neighborhoods more appealing to outsiders, and soon enough, being priced out themselves.
Despite never living here, chef Marcus Samuelsson ––who was born in Ethiopia and raised in Sweden–– says visiting the region feels a bit like a "homecoming."
The majority of journalists we surveyed after the Capital Gazette shooting feel physically safe at work. But emotionally, they're sad, vulnerable, fatigued, uneasy and heartbroken.